🇺🇸 FDA
Pipeline program

QGC001

QUID-HF_v5.0_20171120

Phase 2 small_molecule terminated

Quick answer

QGC001 for Heart Failure is a Phase 2 program (small_molecule) at Quantum Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Quantum Biopharma
Indication
Heart Failure
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials